Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

Cell Immunol. 1988 Apr 1;112(2):364-70. doi: 10.1016/0008-8749(88)90305-x.

Abstract

The oral administration of myelin basic protein (MBP) to Lewis rats prior to an encephalitogenic challenge resulted in total inhibition or a significant delay in the onset of experimental autoimmune encephalomyelitis (EAE). In vitro lymphocyte proliferative responses to MBP were significantly decreased in MBP-fed rats when compared with vehicle-fed controls. Suppression of EAE and in vitro proliferative responses to MBP were observed to be antigen specific, since oral feeding of a control protein exerted no suppressive effect. Moreover, the specificity of MBP-induced oral tolerance was shown to be species specific, since feeding guinea pig MBP (GPMBP) or human MBP (HuMBP) induced protection only against a GPMBP or HuMBP challenge, respectively. Conversely, Lewis rats could not be orally tolerized to the self antigen rat MBP.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Animals
  • Dose-Response Relationship, Immunologic
  • Encephalomyelitis, Autoimmune, Experimental / etiology
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Guinea Pigs
  • Humans
  • Immune Tolerance*
  • Lymphocyte Activation
  • Male
  • Myelin Basic Protein / administration & dosage*
  • Rats
  • Rats, Inbred Lew
  • Species Specificity
  • Trypsin Inhibitors / administration & dosage

Substances

  • Myelin Basic Protein
  • Trypsin Inhibitors